108 related articles for article (PubMed ID: 24558190)
1. SLPI is essential for granulopoiesis.
Nolte MA
Blood; 2014 Feb; 123(8):1121-3. PubMed ID: 24558190
[No Abstract] [Full Text] [Related]
2. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation.
Klimenkova O; Ellerbeck W; Klimiankou M; Ünalan M; Kandabarau S; Gigina A; Hussein K; Zeidler C; Welte K; Skokowa J
Blood; 2014 Feb; 123(8):1239-49. PubMed ID: 24352879
[TBL] [Abstract][Full Text] [Related]
3. Reduced ELANE and SLPI expression compromises dental pulp cell activity.
Sriwattanapong K; Sa-Ard-Iam N; Boonprakong L; Subbalekha K; Trachoo V; Suratannon N; Porntaveetus T; Shotelersuk V
Cell Prolif; 2021 Nov; 54(11):e13132. PubMed ID: 34580954
[TBL] [Abstract][Full Text] [Related]
4. Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis.
Morishima T; Watanabe K; Niwa A; Hirai H; Saida S; Tanaka T; Kato I; Umeda K; Hiramatsu H; Saito MK; Matsubara K; Adachi S; Kobayashi M; Nakahata T; Heike T
Haematologica; 2014 Jan; 99(1):19-27. PubMed ID: 23975175
[TBL] [Abstract][Full Text] [Related]
5. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia.
Skokowa J; Cario G; Uenalan M; Schambach A; Germeshausen M; Battmer K; Zeidler C; Lehmann U; Eder M; Baum C; Grosschedl R; Stanulla M; Scherr M; Welte K
Nat Med; 2006 Oct; 12(10):1191-7. PubMed ID: 17063141
[TBL] [Abstract][Full Text] [Related]
6. Effect of granulocyte colony-stimulating factor on granulopoiesis of congenital neutropenic children.
Benkö I; Maródi L; Megyeri A; Káposzta R; Kovács P
Acta Physiol Hung; 1996; 84(3):261-2. PubMed ID: 9219597
[TBL] [Abstract][Full Text] [Related]
7. Both Granulocytic and Non-Granulocytic Blood Cells Are Affected in Patients with Severe Congenital Neutropenia and Their Non-Neutropenic Family Members: An Evaluation of Morphology, Function, and Cell Death.
Olcay L; Ünal Ş; Onay H; Erdemli E; Öztürk A; Billur D; Metin A; Okur H; Yıldırmak Y; Büyükaşık Y; İkincioğulları A; Falay M; Özet G; Yetgin S
Turk J Haematol; 2018 Nov; 35(4):229-259. PubMed ID: 30040071
[TBL] [Abstract][Full Text] [Related]
8. Functional characteristics of circulating granulocytes in severe congenital neutropenia caused by ELANE mutations.
Liu Q; Sundqvist M; Li W; Holdfeldt A; Zhang L; Björkman L; Bylund J; Dahlgren C; Wang C; Zhao X; Forsman H
BMC Pediatr; 2019 Jun; 19(1):189. PubMed ID: 31176364
[TBL] [Abstract][Full Text] [Related]
9. Enhancing the developmental competence of the early embryo using secretory leukocyte peptidase inhibitor.
Kim HS; Ha KS; Kwon HC; Lee SJ; Kim CH; Cheon YP
Differentiation; 2016; 92(1-2):24-34. PubMed ID: 26927923
[TBL] [Abstract][Full Text] [Related]
10. 5. Mechanisms of disordered granulopoiesis in congenital neutropenia.
Grenda DS; Link DC
Curr Top Dev Biol; 2006; 74():133-76. PubMed ID: 16860667
[TBL] [Abstract][Full Text] [Related]
11. The stage-specific impairment of granulopoiesis in people living with HIV/AIDS (PLWHA) with neutropenia.
Fan L; Han J; Xiao J; Dai G; Hao Y; Yang D; Liang H; Wu L; Song C; Li G; Li B; Wang D; Zeng Y; Pang X; Zhang F; Zeng H; Zhao H
J Leukoc Biol; 2020 Apr; 107(4):635-647. PubMed ID: 32057138
[TBL] [Abstract][Full Text] [Related]
12. Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response.
Majchrzak-Gorecka M; Majewski P; Grygier B; Murzyn K; Cichy J
Cytokine Growth Factor Rev; 2016 Apr; 28():79-93. PubMed ID: 26718149
[TBL] [Abstract][Full Text] [Related]
13.
Olofsen PA; Touw IP
Mol Cells; 2020 Feb; 43(2):139-144. PubMed ID: 32041395
[TBL] [Abstract][Full Text] [Related]
14. GM-CSF stimulates granulopoiesis in a congenital neutropenia patient with loss-of-function biallelic heterozygous CSF3R mutations.
Klimiankou M; Klimenkova O; Uenalan M; Zeidler A; Mellor-Heineke S; Kandabarau S; Skokowa J; Zeidler C; Welte K
Blood; 2015 Oct; 126(15):1865-7. PubMed ID: 26324699
[No Abstract] [Full Text] [Related]
15. [Precursor cells of the granulomonocytopoiesis in children with immune neutropenia].
Gerasimova LP; Kisliak NS; Finogenova NA; Mamedova EA
Gematol Transfuziol; 1990 Feb; 35(2):13-5. PubMed ID: 2332129
[TBL] [Abstract][Full Text] [Related]
16. The CD40/CD40 ligand interactions exert pleiotropic effects on bone marrow granulopoiesis.
Mavroudi I; Papadaki V; Pyrovolaki K; Katonis P; Eliopoulos AG; Papadaki HA
J Leukoc Biol; 2011 May; 89(5):771-83. PubMed ID: 21367977
[TBL] [Abstract][Full Text] [Related]
17. Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-κB signaling pathway.
Mikami Y; Iwase T; Komiyama Y; Matsumoto N; Oki H; Komiyama K
Mol Immunol; 2015 Oct; 67(2 Pt B):568-74. PubMed ID: 26239418
[TBL] [Abstract][Full Text] [Related]
18. Secretory Leukocyte Protease Inhibitor (SLPI): Emerging Roles in CNS Trauma and Repair.
Hannila SS
Neuroscientist; 2015 Dec; 21(6):630-6. PubMed ID: 25118190
[TBL] [Abstract][Full Text] [Related]
19. Defects of granulopoiesis in patients with severe congenital neutropenia.
Nakamura K; Kobayashi M; Konishi N; Kawaguchi H; Miyagawa S; Sato T; Katoh O; Ueda K
Hiroshima J Med Sci; 2002 Sep; 51(3):63-74. PubMed ID: 12422946
[TBL] [Abstract][Full Text] [Related]
20. Long-term use of pegfilgrastim in children with severe congenital neutropenia: clinical and pharmacokinetic data.
Fioredda F; Lanza T; Gallicola F; Riccardi F; Lanciotti M; Mastrodicasa E; Signa S; Zanardi S; Calvillo M; Dufour C
Blood; 2016 Oct; 128(17):2178-2181. PubMed ID: 27621310
[No Abstract] [Full Text] [Related]
[Next] [New Search]
